ORGANIC
LETTERS
2008
Vol. 10, No. 15
3251-3253
Synthetic Studies on (+)-Manzamine A:
Stereoselective Synthesis of the
Tetracyclic Core Framework
Yoichi Kita,† Tatsuya Toma,† Toshiyuki Kan,‡ and Tohru Fukuyama*,†
Graduate School of Pharmaceutical Sciences, UniVersity of Tokyo, 7-3-1 Hongo,
Bunkyo-ku, Tokyo, Japan, and School of Pharmaceutical Sciences, UniVersity of
Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka, Japan
kant@u-shizuoka-ken.ac.jp; fukuyama@mol.f.u-tokyo.ac.jp
Received May 14, 2008
ABSTRACT
The stereoselective synthesis of the tetracyclic intermediate 3 for (+)-manzamine A (1) has been achieved. The key features of this stereoselective
synthesis of 3 are the Rh-catalyzed asymmetric hydrogenation and a diastereoselective intermolecular Diels-Alder reaction. The 8-membered
ring is efficiently constructed utilizing our Ns-strategy.
Manzamine A (1), a naturally occurring ꢀ-carboline alkaloid
isolated from a sponge of genus Haliclona by Higa1 and
from genus Pellina by Kobayashi,2 has shown numerous
biological activities, including cytotoxic,1 antibacterial,2
antimalarial,3 insecticidal,4 anti-inflammatory,5 and anti-HIV6
activities. The remarkable biological activities coupled with
its highly complex structure have made it an attractive total
synthesis target, and several synthetic studies on this family
of compounds have been published.7 However, only three
total syntheses8 have been reported to date. The crucial step
in the synthesis of 1 should be the construction of the
complex pentacyclic skeleton because the ready conversion
from its biosynthetic precursor ircinal A (2) to 1 is known.9
Herein, we report the stereocontrolled synthesis of tetracyclic
intermediate 3 for the total synthesis of (+)-1 (Scheme 1).
We envisioned that formation of the D ring and addition
of the C1 unit to the vinylogous ester 3 could be achieved
† University of Tokyo.
‡ University of Shizuoka.
(1) (a) Sakai, R.; Higa, T.; Jefford, C. W.; Bernardinelli, G. J. Am. Chem.
Soc. 1986, 108, 6404.
(6) Rao, K. V.; Donia, M. S.; Peng, J.; Garcia-Palomero, E.; Alonso,
D.; Martinez, A.; Medina, M.; Franzblau, S. G.; Tekwani, B. L.; Khan,
S. I.; Wahyuono, S.; Willett, K. L.; Hamann, M. T. J. Nat. Prod. 2006, 69,
1034.
(2) Nakamura, H.; Deng, S.; Kobayashi, J.; Ohizumi, Y.; Tomotake,
Y.; Matsuzaki, T.; Hirata, Y. Tetrahedron Lett. 1987, 28, 621.
(3) (a) Ang, K. K. H.; Holmes, M. J.; Higa, T.; Hamann, M. T.; Kara,
U. A. K. Antimicrob. Agents Chemother. 2000, 44, 1645. (b) El Sayed,
K. A.; Kelly, M.; Kara, U. A. K.; Ang, K. K. H.; Katsuyama, I.; Dunbar,
D. C.; Khan, A. A.; Hamann, M. T. J. Am. Chem. Soc. 2001, 123, 1804.
(c) Winkler, J. D.; Londregan, A. T.; Hamann, A. T. Org. Lett. 2006, 8,
2591. (d) Winkler, J. D.; Londregan, A. T.; Ragains, J. R.; Hamann, A. T.
Org. Lett. 2006, 8, 3407. (e) Winkler, J. D.; Londregan, A. T.; Hamann,
A. T. Org. Lett. 2007, 9, 4467.
(7) For reviews of manzamine alkaloid, see: (a) Tsuda, M.; Kobayashi,
J. Heterocycles 1997, 46, 725. (b) Magnier, E.; Langlois, Y. Tetrahedron
1998, 54, 6201.
(8) (a) Winkler, J. D.; Axten, J. M. J. Am. Chem. Soc. 1998, 120, 6425.
(b) Martin, S. F.; Humphrey, J. M.; Ali, A.; Hillier, M. C J. Am. Chem.
Soc. 1999, 121, 866. (c) Humphrey, J.; Liao, Y.; Ali, A.; Rein, T.; Wong,
Y.-L.; Chen, H.-J.; Courtney, A. K.; Martin, S. F. J. Am. Chem. Soc. 2002,
124, 8584. (d) Tokumaru, K.; Arai; S., ; Nishida, A. 126th Annual Meeting
of the Pharmaceutical Society of Japan, Sendai, 2006; 028[F]-031.
(9) (a) Kondo, K.; Shigemori, H.; Kikuchi, Y.; Ishibashi, M.; Sasaki,
T.; Kobayashi, J. J. Org. Chem. 1992, 57, 2480. (b) Choo, Y.-M.; Hamann,
M. T Heterocycles 2007, 71, 245.
(4) Edrada, R. A.; Proksch, P.; Wray, V.; Witte, L.; Mu¨ller, W. E. G.;
Van Soest, R. W. M. J. Nat. Prod. 1996, 59, 1056.
(5) Mayer, A. M. S.; Gunasekara, S. P.; Pomponi, S. A.; Sennet, S. H.
PCT Int. Appl., WO 0056304 A2 20000928, 2000.
10.1021/ol801111r CCC: $40.75
Published on Web 07/03/2008
2008 American Chemical Society